European Journal of Cancer
Volume 46, Issue 2 , Pages 449-455 , January 2010

[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study

  • T. Steuber

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
    • Corresponding Author InformationCorresponding author: Tel.: +49 40 7410 51300; fax: +49 40 7410 51323.
    • ,
  • T. Schlomm

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
    • ,
  • H. Heinzer

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
    • ,
  • M. Zacharias

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • S. Ahyai

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • K.F. Chun

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • A. Haese

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • S. Klutmann

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • J. Köllermann

      Affiliations

    • Department of Pathology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • G. Sauter

      Affiliations

    • Department of Pathology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • J. Mester

      Affiliations

    • Department of Nuclear Medicine, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • P. Mikecz

      Affiliations

    • Nuclear Medicine Center, Radiochemistry Center, University of Debrecen, Hungary
    • ,
  • M. Fisch

      Affiliations

    • Department of Urology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • H. Huland

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
    • ,
  • M. Graefen

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
    • ,
  • G. Salomon

      Affiliations

    • Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany

Received 16 June 2009 ,Revised 21 September 2009 ,Accepted 12 November 2009.

References 

  1. Hull GW, Rabbani F, Abbas F, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002;167(2 Pt. 1):528–534
  2. Da Pozzo LF, Cozzarini C, Briganti A, et al. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Eur Urol. 2009;55(5):1003–1011
  3. Boorjian SA, Thompson RH, Siddiqui S, et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol. 2007;178(3 Pt. 1):864–870[discussion 870–1]
  4. Messing EM, Manola J, Yao J, et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol. 2006;7(6):472–479
  5. Hovels AM, Heesakkers RA, Adang EM, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387–395
  6. Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol. 2008;53(1):118–125
  7. Jeschke S, Beri A, Grull M, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol. 2008;53(1):126–132
  8. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl J Med. 2003;348(25):2491–2499
  9. Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol. 2008;54(3):589–600
  10. de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med. 2003;44(3):331–335
  11. Fricke E, Machtens S, Hofmann M, et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2003;30(4):607–611
  12. Hara T, Kosaka N, Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43(2):187–199
  13. Schiavina R, Scattoni V, Castellucci P, et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol. 2008;54(2):392–401
  14. Hacker A, Jeschke S, Leeb K, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2006;176(5):2014–2018[discussion 2018–9]
  15. Husarik DB, Miralbell R, Dubs M, et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35(2):253–263
  16. Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol. 2006;49(6):1019–1026[discussion 1026–7]
  17. Epstein JI, Allsbrook WC, Amin MB, Egevad LL. The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228–1242
  18. Graefen M, Walz J, Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur Urol. 2006;49(1):38–48
  19. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897–906
  20. Greene FL, Sobin LH. The TNM system: our language for cancer care. J Surg Oncol. 2002;80(3):119–120
  21. Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol. 2003;170(5):1798–1803
  22. Yoshimoto M, Waki A, Obata A, et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol. 2004;31(7):859–865
  23. DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110–117
  24. Budiharto TJS, Lerut E, Haustermans K, et al. Evaluation of Choline (Chol) PET CT and diffusion weighted (DW) MRI for the nodal staging of Prostate Cancer (PCa) with a high risk of lymph node (LN) metastases. Eur Urol Suppl. 2009;8(4):121–416
  25. Schumacher DSJ, Brekkan E, Wassberg C, Malmström PU. The value of C11-acetate PET for Lymph node staging in patients with newly diagnosed prostate cancer – results of a prospective study. Eur Urol Suppl. 2009;8(4):121–416
  26. Scattoni V, Picchio M, Suardi N, et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol. 2007;52(2):423–429
  27. Schilling D, Schlemmer HP, Wagner PH, et al. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int. 2008;102(4):446–451
  28. Rinnab L, Mottaghy FM, Blumstein NM, et al. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int. 2007;100(4):786–793
  29. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25(15):2035–2041

PII: S0959-8049(09)00846-6

doi: 10.1016/j.ejca.2009.11.008

European Journal of Cancer
Volume 46, Issue 2 , Pages 449-455 , January 2010

Article Tools

* Image Usage & Resolution